William Blair & Company
LMAT icon

William Blair & Company’s LeMaitre Vascular LMAT Stock Holding History

William Blair & Company’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,807
Closed -$213K – 1442
2017
Q2 		$213K Sell
6,807
-5,170
-43% -$149K ﹤0.01% 1318
2017
Q1 		$295K Buy
11,977
+768
+7% +$18K ﹤0.01% 1082
2016
Q4 		$284K Sell
11,209
-7,060
-39% -$157K ﹤0.01% 1028
2016
Q3 		$362K Buy
18,269
+1,880
+11% +$32.8K ﹤0.01% 950
2016
Q2 		$234K Buy
16,389
+140
+0.9% +$2.14K ﹤0.01% 1069
2016
Q1 		$252K Buy
16,249
+1,020
+7% +$14.6K ﹤0.01% 990
2015
Q4 		$263K Buy
15,229
+749
+5% +$10.8K ﹤0.01% 993
2015
Q3 		$177K Sell
14,480
-427,841
-97% -$5.49M ﹤0.01% 1299
2015
Q2 		$5.33M Sell
442,321
-4,958
-1% -$48.8K 0.01% 1057
2015
Q1 		$3.75M Buy
447,279
+118,000
+36% +$926K 0.01% 1128
2014
Q4 		$2.52M Buy
+329,279
New +$2.36M ﹤0.01% 1227

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair & Company's LMAT Position: Q3 2017 in Review

William Blair & Company sold out of LeMaitre Vascular (LMAT) in Q3 2017, closing a stake of 6,807 shares — an estimated $213K sold.

William Blair & Company first reported a position in LMAT in Q4 2014 and held it in 11 quarters. The position peaked at $5.33M in Q2 2015. 148 funds tracked by Wall St. Rank hold LMAT as of Q3 2017.

  • William Blair & Company reported no remaining LeMaitre Vascular position as of Q3 2017 after selling out during the quarter.
  • William Blair & Company sold 6,807 LeMaitre Vascular shares in Q3 2017, an estimated $213K.
  • William Blair & Company first reported a position in LeMaitre Vascular in Q4 2014 and held it in 11 quarters.
  • William Blair & Company's LeMaitre Vascular position peaked at $5.33M in Q2 2015.
  • 148 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2017.

Based on William Blair & Company's 13F filing for Q3 2017, filed 13 Nov 2017.